SCHEMBL30453017

SCHEMBL30453017

COc1cccc(OC)c1-c1cnc(N)c(OC(C)c2c(Cl)ccc(F)c2Cl)c1

nearest known ligand 0.74

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MET P08581 12/20 0.74
JAK2 O60674 1/20 0.69
ALK Q9UM73 7/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL488864 1.00 MET (0.74) METJAK2ALK
SCHEMBL487929 0.91 MET (0.78) METJAK2ALK
SCHEMBL30453103 0.91 MET (0.78) METJAK2ALK
SCHEMBL30454855 0.89 MET (0.76) METJAK2ALK
SCHEMBL488681 0.89 MET (0.76) METJAK2ALK
SCHEMBL17310261 0.88 MET (0.77) METJAK2ALK
SCHEMBL17310259 0.88 MET (0.77) METJAK2ALK
SCHEMBL488358 0.87 MET (0.70) METJAK2ALK
SCHEMBL30452840 0.87 MET (0.70) METJAK2ALK
SCHEMBL30452774 0.87 MET (0.76) METJAK2ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113181362-B Medicament for preventing and/or treating amyotrophic lateral sclerosis 国立大学法人京都大学 2023-06-13 CN disclosed